In RA patients, prolonged and sustained activation of the immune system may drive the initiation and progression of cancer, potentially mediated by interleukin-6 (IL-6), which could serve as a common link between RA and cancer [35]. The gene discussed is IL6; the disease is rheumatoid arthritis.